Benitec Biopharma Ltd (BNTC)

[Blane]

End of Phase I/Phase IIa timeline of TT-034 trial.

When asked if November of 2016 would be the end of the trial, here were Pannobhaso's comments. Very insightful.

http://seekingalpha.com/instablog/19837781-pannobhaso/3040525-ttminus-034-not-a-binary-outcome-for-benitec


Author’s reply »"If everything went without a hitch then the end of Nov 2015 could be achieved. I think the more likely outcome is Jan 2016 because of the number of reviews required of the DSMB, each of which could add a week or more to the timetable.

What I am hoping is that the data from cohort four will be sufficient to allow the company to plan for the next trial, a Pllb trial. This would allow them to get a lot of the planning and preparation done while cohort five is still awaiting results.

The company has always maintained that it needs to be in a Pllb trial before it can do a deal on TT-034 and so the sooner we can get to that stage, the better.

As we are also going to be running a NSCLC trail in 2015, the timing of "doing a deal" is going to be critical as we start to see our cash burn rate increase over the next twelve months.

I am hearing that the AMD program has some interest and, now that we have our own lab, I would expect that program to advance quickly through the pre-clinical stage. As I understand it, the two scientist we have just hired to work in our lab are two that worked on the AMD program for Tacere before Benitec took over, so they have hit the floor running.

It is also possible that a deal could be done on this program while it is still in pre-clinical development. A deal could happen anytime and any deal would see the pps take off This is why I am long on Benitec rather than a trader."